Fundraising Fox

Paul Thompson

CDO at NRG Therapeutics

Greater Cambridge Area

Find your path to Paul

392 people in our graph share verified history with Paul — schools, employers, funds. One of them is your warm intro.

Jan HammerunlockedPaul: together at University of Oxford (1995–1998)
×6Paul: together at GlaxoSmithKline
Paul: together at UCL
×4Paul: together at University of Oxford

CDO at NRG Therapeutics

Intro paths

→

In turn, Paul can intro founders to NRG Therapeutics's investors below.

NRG Therapeutics's investors · 6

British Business BankSheffield · since 2025Criteria Bio VenturesBarcelona · since 2025Dementia Discovery FundLondon · since 2025M VenturesLos Angeles · $10.8M checks · since 2025Novartis Venture FundBasel · $5M – $25M checks · since 2025SV Health InvestorsBoston · $1M – $20M checks

Co-founders at NRG Therapeutics

NMNeil Miller
Neil MillerCEO
RR
Richard RutterCSO

Experience

  1. NRG TherapeuticsChief Development Officercurrent2025 — present
  2. Mission TherapeuticsChief Scientific Officer2020 — 2025
  3. Mission TherapeuticsVP Clinical Development2018 — 2020Greater Cambridge Area
  4. Mission TherapeuticsMedical Director, CNS Translational Medicine2016 — 2018Greater Cambridge Area
  5. ONO PHARMA UK LTDClinical Science Director2014 — 2016
  6. GlaxoSmithKlineDirector2012 — 2014
  7. GlaxoSmithKlineAssociate Director2010 — 2012
  8. GlaxoSmithKlineManager/Senior Investigator2006 — 2010

Skills & more

Clinical Development32Drug Discovery18

From Paul's professional profile.

Frequently asked questions

Who is Paul Thompson?
CDO at NRG Therapeutics
Where does Paul Thompson work?
Paul Thompson is CDO at NRG Therapeutics.
Where did Paul Thompson go to school?
Paul Thompson studied at University of Oxford (MBiochem, Molecular and Cellular Biochemistry); UCL (Doctor of Philosophy (PhD), Immuno and cell biology).

Same school

Also attended University of Oxford1,772

Reid HoffmanCo-founder of LinkedIn; Partner at GreylockMichael MoritzFormer Partner at Sequoia Capital; Senior Adviser at Sequoia HeritageGabriel PereyraCo-founder & President of HarveyDominic JacquessonInvestor at Index VenturesErin Price-WrightInvestor at Index VenturesJan HammerInvestor at Index Ventures

+ 1,766 more

Also attended UCL706

Demis HassabisCo-founder & CEO of Google DeepMindAndré DuboisInvestor at Index VenturesFrédérique DameInvestor at GV (Google Ventures)Jonas VetterleInvestor at Moonfire VenturesMarie FerriInvestor at DaphniElena PantaziPartner & Head of Platform at Northzone

+ 700 more

Shared employers

Also worked at NRG Therapeutics9

Mathias FrederiksenPrincipal at Novartis Venture FundHakan GokerManaging Director at M VenturesFrancesco DraettaManaging Director at Omega FundsAlex DelbridgeSenior Associate at Omega FundsGeorgia FrostSenior Associate at Dementia DiscoveryPablo CironiManaging Director at Criteria Bio Ventures

+ 3 more

Also worked at Mission Therapeutics5

Jonathan HeppleManaging Partner at Rosetta Capital Ltd.Deborah HarlandChair, LifeArc Ventures Investment Committee at LifeArc VenturesAnne PhelanDDF SAB Member at Dementia Discovery FundSir Steve JacksonFounding Partner at Ahren Innovation CapitalSteve JacksonPartner at Ahren Innovation Capital

Also worked at GlaxoSmithKline279

Sam BlackmanEntrepreneur in Residence at GV (Google Ventures)Victoria TaylorInvestor at MedicxiErin MooreInvestor at Third Rock VenturesJeb KeiperInvestor at Third Rock VenturesJane SuhPrincipal on the AlleyCorp Healthcare teamCarol SuhPartner at ARCH Venture Partners

+ 273 more